Celgene’s blood cancer pill too expensive for NHS
February 13, 2015Sales and Marketing Celgene, NHS, NICE, Pomalidomide, imnovid, myeloma
NICE has decided not to recommend Celgene’s Imnovid for treating patients with multiple myeloma – a cancer that affects white …
Boehringer and Sanofi admit to code breaches
February 13, 2015Medical Communications, Sales and Marketing ABPI, Boehringer, PMCPA, Sanofi, afatinib, giotrif
Sanofi and Boehringer Ingelheim have both admitted to breaching the ABPI Code of Practice, with Sanofi set to be publicly …
Sanofi makes gene therapy move
February 13, 2015Research and Development, Sales and Marketing Genzyme, Sanofi, Voyager Therapeutics, gene therapy, merger
Sanofi has signalled its intent to develop gene therapy treatments for nerve diseases through a $745 million deal with US …
New director at IMC Healthcare Communication
February 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing imc healthcare communication, stephanie westwood
Dr Stephanie Westwood has joined IMC Healthcare Communication as a medical and scientific director. Westwood was previously a scientific director …
Google search results to include health facts
February 12, 2015Medical Communications, Sales and Marketing digital, google, health, internet, knowledge graph, wearables
Google is set to introduce health information directly into its search results as increasing numbers of people use search engines …
Websites selling illegal drugs increasingly face closure
February 12, 2015Manufacturing and Production, Medical Communications, Sales and Marketing MHRA, counterfeit, drugs, illegal, on tap, websites
The number of websites shut down by the MHRA for selling illegal pharmaceutical products has increased dramatically in recent years, …
New support guidelines for NHS whistleblowers
February 12, 2015Medical Communications, Sales and Marketing CCG, Jeremy Hunt, NHS, comms, robert francis, whistleblowers
New guidelines to support NHS whistleblowers have been proposed by Sir Robert Francis QC – who led the inquiry into …
Apple hails health benefits of new watch
February 12, 2015Medical Communications, Sales and Marketing Apple, FDA, cook, healthkit, watch, wearables
Users of the upcoming Apple Watch will be prompted to be more active because ‘sitting is the new cancer’ according …
RSA hires three new consultants
February 12, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Beatriz de Luis, Maria-Angeles Garcia, Omar de Bary, rsa
Executive search and interims specialist firm RSA has announced three new appointments to its team of consultants in the UK. …
Pharma is boosting pipelines to avoid patent cliff
February 11, 2015Sales and Marketing Biogen IDEC, Moody's, dimethyl fumarate, lilly, pharma, pipelines, sofosbuvir, sovaldi, tecfidera
Pharmaceutical companies have improved their pipelines of new drugs over the last 18 months according to financial analysts Moody’s Investors …
US measles outbreak worst for 15 years
February 11, 2015Sales and Marketing FDA, cdcp, hamburg, measles, priorix, trimovax, vaccines
The worst measles outbreak in 15 years has reached a startling 121 cases in the US alone according to the …
GSK buys bacteria vaccine firm
February 11, 2015Research and Development, Sales and Marketing EC, GSK, GlaxoSmithKline, GlycoVaxyn, Novartis, vaccines
GlaxoSmithKline is continuing the significant expansion of its vaccine business with the purchase of Swiss biopharma company GlycoVaxyn. The UK …
MRC Technology hires senior head from Shire
February 11, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edward Bliss, MRC, Shire
UK medical research charity MRC Technology has appointed Dr Edward Bliss to the new role of general counsel and company …
Pharma’s reputation ‘is worsening among patients’
February 10, 2015Medical Communications, Research and Development, Sales and Marketing HIV, ViiV Healthcare, patientview, pharma, reputation, transparency
Only around four in ten patients believe pharma has a good reputation and many companies are failing to win patient …
Charity challenges Sovaldi patent
February 10, 2015Sales and Marketing Gilead, HCV, Médecins du Monde, sofosbuvir, sovaldi, world health organization
Doctors of the World (also known as Médecins du Monde) has filed an opposition to the patent for Gilead’s blockbuster …
Gilead expands UK presence with new London HQ
February 10, 2015Research and Development, Sales and Marketing Cambridge, Gilead, London, NICE, UK, johnson, medcity, sovaldi, uxbridge
Gilead is to create a new UK commercial secondary headquarters in central London doubling its UK workforce to 600 by …
Second late-stage COPD trial for GSK and Theravance
February 10, 2015Sales and Marketing COPD, FF/UMEC/VI, GSK, Theravance, fluticasone furoate, umeclidinium, vilanterol
GlaxoSmithKline and Theravance have begun a second Phase III trial of their investigational triple combination COPD drug as the former …
Hospira recalls Propofol drug again
February 10, 2015Manufacturing and Production, Sales and Marketing Hospira, Pfizer, diprivan, manufacturing, merger, propofol
Hospira has issued a recall of anaesthesia support drug Propofol after the neck of one vial was revealed to contain …
Pfizer replaces UK managing director
February 10, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Erik Nordkamp, Pfizer, jonathan emms
Erik Nordkamp has been named as the managing director of Pfizer UK to take over from Jonathan Emms. Emms has …
MHRA shuts down unlicensed cancer drug facility
February 9, 2015Manufacturing and Production, Sales and Marketing Cambridge, GcMAF, MHRA, first immune, globulin component macrophage activating factor
The MHRA has shut down an unlicensed Cambridgeshire plant that was producing a potentially dangerous drug to be sold online. …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
